Paola Rogliani to Phosphodiesterase 3 Inhibitors
This is a "connection" page, showing publications Paola Rogliani has written about Phosphodiesterase 3 Inhibitors.
Connection Strength
0.050
-
Ensifentrine (RPL554): an investigational PDE3/4 inhibitor for the treatment of COPD. Expert Opin Investig Drugs. 2019 Oct; 28(10):827-833.
Score: 0.050
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.